|
Symbol
|
ACLSSQ | RMA09V | Z0BA0Z | QRYRCH | Z0BCLZ | Z0BDSZ | LARBDU | Z0BO6Z | Z0BPNZ | LBFYDU | AEVDTQ | Z0BVCZ | Z0BWTZ | Z0C0RZ | Z0C28Z |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible |
|
Basiswert
|
Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | L'Oréal S.A. / Philips Electronics N.V. / SAP SE | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Adyen N.V. / Prosus / Royal Philips Electronics N.V. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | EssilorLuxottica S.A. / Fresenius Medical Care AG & Co. KGaA (St) / Royal Philips Electronics N.V. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. | Bayer AG / Philips Electronics N.V. / Roche PS / Sanofi S.A. | Bayer AG / Royal Philips Electronics N.V. / Sanofi S.A. |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
19.05.2026 | 12.05.2027 | 09.07.2026 | 11.01.2027 | 28.07.2026 | 04.08.2026 | 07.08.2026 | 15.10.2026 | 26.10.2026 | 05.05.2027 | 18.08.2027 | 28.05.2027 | 08.12.2026 | 22.01.2027 | 02.02.2027 |
| Geld | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Brief | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |